Bruker [BRKR] vs Stryker [SYK] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Bruker Corporation wins in 5 metrics, Stryker Corporation wins in 16 metrics, with 0 ties. Stryker Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bruker Corporation | Stryker Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 74.88 | 39.21 | Stryker Corporation |
| Price-to-Book Ratio | 2.24 | 5.62 | Bruker Corporation |
| Debt-to-Equity Ratio | 81.38 | 72.97 | Stryker Corporation |
| PEG Ratio | 6.74 | 0.72 | Stryker Corporation |
| EV/EBITDA | 14.63 | 19.90 | Bruker Corporation |
| Profit Margin (TTM) | -0.25% | 12.92% | Stryker Corporation |
| Operating Margin (TTM) | 6.58% | 27.24% | Stryker Corporation |
| EBITDA Margin (TTM) | 6.58% | 27.24% | Stryker Corporation |
| Return on Equity | -0.38% | 15.08% | Stryker Corporation |
| Return on Assets (TTM) | 2.90% | 7.92% | Stryker Corporation |
| Free Cash Flow (TTM) | $13.90M | $4.28B | Stryker Corporation |
| Dividend Yield | 0.65% | 0.97% | Stryker Corporation |
| 1-Year Return | 41.59% | -17.25% | Bruker Corporation |
| Price-to-Sales Ratio (TTM) | 1.60 | 5.02 | Bruker Corporation |
| Enterprise Value | $7.31B | $138.30B | Stryker Corporation |
| EV/Revenue Ratio | 2.13 | 5.51 | Bruker Corporation |
| Gross Profit Margin (TTM) | 45.97% | 64.54% | Stryker Corporation |
| Revenue per Share (TTM) | $23 | $66 | Stryker Corporation |
| Earnings per Share (Diluted) | $-0.15 | $8.40 | Stryker Corporation |
| Beta (Stock Volatility) | 1.20 | 0.93 | Stryker Corporation |
| Short % of Float | 17.68% | 1.20% | Stryker Corporation |
Bruker Corporation vs Stryker Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bruker Corporation | 4.43% | 0.66% | 32.07% | 72.86% | 24.00% | 17.71% |
| Stryker Corporation | -1.36% | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bruker Corporation | 41.59% | -28.15% | -24.98% | 125.58% | 203.81% | 984.60% |
| Stryker Corporation | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
Performance & Financial Health Analysis: Bruker Corporation vs Stryker Corporation
| Metric | BRKR | SYK |
|---|---|---|
| Market Information | ||
| Market Cap | $5.56B | $126.25B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 2,049,283 | 1,881,406 |
| 90 Day Avg. Volume | 2,108,108 | 2,161,139 |
| Last Close | $56.63 | $307.94 |
| 52 Week Range | $28.53 - $64.54 | $281.00 - $404.87 |
| % from 52W High | -12.26% | -23.94% |
| All-Time High | $94.86 (Mar 18, 2024) | $406.19 (Jan 27, 2025) |
| % from All-Time High | -40.30% | -24.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.11% |
| Quarterly Earnings Growth | 0.90% | 0.56% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.13% |
| Operating Margin (TTM) | 0.07% | 0.27% |
| Return on Equity (TTM) | 0.00% | 0.15% |
| Debt to Equity (MRQ) | 81.38 | 72.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.15 | $58.61 |
| Cash per Share (MRQ) | $1.96 | $10.71 |
| Operating Cash Flow (TTM) | $134.10M | $5.04B |
| Levered Free Cash Flow (TTM) | $216.96M | $4.17B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.65% | 0.97% |
| Last 12-Month Dividend | $0.25 | $3.40 |
Valuation & Enterprise Metrics Analysis: Bruker Corporation vs Stryker Corporation
| Metric | BRKR (Apr 26, 2026) | SYK (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 74.88 | 39.21 |
| Forward P/E | 15.01 | 19.67 |
| PEG Ratio | 6.74 | 0.72 |
| Price to Sales (TTM) | 1.60 | 5.02 |
| Price to Book (MRQ) | 2.24 | 5.62 |
| Market Capitalization | ||
| Market Capitalization | $5.56B | $126.25B |
| Enterprise Value | $7.31B | $138.30B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.13 | 5.51 |
| Enterprise to EBITDA | 14.63 | 19.90 |
| Risk & Other Metrics | ||
| Beta | 1.20 | 0.93 |
| Book Value per Share (MRQ) | $16.15 | $58.61 |
Financial Statements Comparison: Bruker Corporation vs Stryker Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BRKR (2025) | SYK (2025) |
|---|---|---|
| Revenue/Sales | 3.44B | 25.12B |
| Cost of Goods Sold | 1.86B | 9.05B |
| COGS % of Revenue | 54.1% | 36.0% |
| Gross Profit | 1.58B | 16.07B |
| Gross Margin | 45.9% | 64.0% |
| Research & Development | 395.20M | 1.62B |
| Operating Income (EBIT) | 236.00M | 5.06B |
| Operating Margin | 6.9% | 20.1% |
| EBITDA | 456.80M | 6.48B |
| EBITDA Margin | 13.3% | 25.8% |
| Pre-Tax Income | 22.00M | 4.51B |
| Pre-Tax Income % of Revenue | 0.6% | 18.0% |
| Income Tax | 29.30M | 1.27B |
| Income Tax % of Revenue | 0.9% | 5.0% |
| Net Income (Profit) | -8.30M | 3.25B |
| Profit Margin | -0.2% | 12.9% |
Balance Sheet & Liquidity Metrics
| Metric | BRKR (2025) | SYK (2025) |
|---|---|---|
| Cash & Equivalents | 298.80M | 4.01B |
| Total Current Assets | 2.21B | 14.76B |
| Total Current Assets % of Revenue | 64.4% | 58.7% |
| Total Current Liabilities | 1.28B | 7.79B |
| Total Current Liabilities % of Revenue | 37.2% | 31.0% |
| Long-Term Debt | 1.99B | 14.86B |
| Long-Term Debt % of Revenue | 57.9% | 59.2% |
| Total Shareholders Equity | 2.51B | 22.42B |
| Retained Earnings | 2.36B | 20.47B |
| Retained Earnings % of Revenue | 68.7% | 81.5% |
| Property, Plant & Equipment | 165.80M | 1.79B |
Cash Flow Statement Comparison
| Metric | BRKR (2025) | SYK (2025) |
|---|---|---|
| Operating Cash Flow | 82.50M | 4.70B |
| Operating Cash Flow % of Revenue | 2.4% | 18.7% |
| Capital Expenditures | -90.80M | -761.00M |
| Free Cash Flow | 13.90M | 4.28B |
| FCF Margin | 0.4% | 17.1% |
| Debt Repayment | -1.25B | -1.40B |
| Common Stock Repurchase | -10.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BRKR | SYK |
|---|---|---|
| Shares Short | 12.53M | 4.42M |
| Short Ratio | 6.30 | 1.95 |
| Short % of Float | 17.68% | 1.20% |
| Shares Outstanding | 152.14M | 382.50M |
| Float Shares | 103.57M | 346.55M |
| % Held by Insiders | 26.95% | 5.37% |
| % Held by Institutions | 91.32% | 82.09% |
| % Held by Public | -18.27% | 12.54% |
Dividend Analysis & Yield Comparison: Bruker Corporation vs Stryker Corporation
| Metric | BRKR | SYK |
|---|---|---|
| Last 12-Month Dividend | $0.25 | $3.40 |
| Last 12-Month Dividend Yield | 0.65% | 0.97% |
| 3-Year Avg Annual Dividend | $0.20 | $3.23 |
| 3-Year Avg Dividend Yield | 0.10% | 0.24% |
| 3-Year Total Dividends | $0.60 | $9.69 |
| Ex-Dividend Date | Mar 23, 2026 | Dec 31, 2025 |